Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis H Miller

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Science Advances|February 21, 2020
A single-nucleotide polymorphism in a <i>Plasmodium berghei</i> ApiAP2 transcription factor alters the development of host immunityMunir Akkaya, Abhisheka Bansal, Patrick W Sheehan, et al.
Elife|June 27, 2018
NK cells inhibit <i>Plasmodium falciparum</i> growth in red blood cells via antibody-dependent cellular cytotoxicityGunjan Arora, Geoffrey T Hart, Javier Manzella-Lapeira, et al.
Plos One|February 14, 2008
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian childrenAlassane Dicko, Issaka Sagara, Ruth D Ellis, et al.
Infection and Immunity|May 24, 2005
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malariaElissa M Malkin, David J Diemert, Julie H McArthur, et al.
Scientific Reports|October 21, 2016
Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen statusYang Cheng, Feng Lu, Bo Wang, et al.
The Journal of Infectious Diseases|February 26, 2026
Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trialBrittany A Riggle, Athanasios Chamzas, Mathangi Gopalakrishnan, et al.
Plos Pathogens|May 27, 2010
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infectionsGreta E Weiss, Boubacar Traore, Kassoum Kayentao, et al.
Plos Clinical Trials|April 7, 2007
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malariaElissa Malkin, Carole A Long, Anthony W Stowers, et al.
Plos One|July 10, 2008
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51Yimin Wu, Ruth D Ellis, Donna Shaffer, et al.
The Journal of Biological Chemistry|July 28, 2009
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateMatthew L Plassmeyer, Karine Reiter, Richard L Shimp, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Science Advances|February 21, 2020
A single-nucleotide polymorphism in a <i>Plasmodium berghei</i> ApiAP2 transcription factor alters the development of host immunityMunir Akkaya, Abhisheka Bansal, Patrick W Sheehan, et al.
Elife|June 27, 2018
NK cells inhibit <i>Plasmodium falciparum</i> growth in red blood cells via antibody-dependent cellular cytotoxicityGunjan Arora, Geoffrey T Hart, Javier Manzella-Lapeira, et al.
Plos One|February 14, 2008
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian childrenAlassane Dicko, Issaka Sagara, Ruth D Ellis, et al.
Infection and Immunity|May 24, 2005
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malariaElissa M Malkin, David J Diemert, Julie H McArthur, et al.
Scientific Reports|October 21, 2016
Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen statusYang Cheng, Feng Lu, Bo Wang, et al.
The Journal of Infectious Diseases|February 26, 2026
Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trialBrittany A Riggle, Athanasios Chamzas, Mathangi Gopalakrishnan, et al.
Plos Pathogens|May 27, 2010
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infectionsGreta E Weiss, Boubacar Traore, Kassoum Kayentao, et al.
Plos Clinical Trials|April 7, 2007
Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malariaElissa Malkin, Carole A Long, Anthony W Stowers, et al.
Plos One|July 10, 2008
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51Yimin Wu, Ruth D Ellis, Donna Shaffer, et al.
The Journal of Biological Chemistry|July 28, 2009
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateMatthew L Plassmeyer, Karine Reiter, Richard L Shimp, et al.
Pageof 17